Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / May / Robotic Phlebotomy Trial What the Patients Said
Clinical care Technology and innovation Research and Innovations Voices in the Community Workforce Trends

Robotic Phlebotomy Trial: What the Patients Said

Experts reflect on the future of phlebotomy in the light of new study results

By Helen Bristow 05/27/2026 Interview 6 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Thought Leaders

Share

Clinical Scorecard: Robotic Phlebotomy Trial: What the Patients Said

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdult patients (18 years and older); not suitable for young children or unconscious patients.
Care Setting

Key Highlights

  • First-stick success rate of ARPD rivals that of manual phlebotomists.
  • 82% of patients preferred or had no preference for using ARPD again.
  • 90% of patients reported satisfaction with comfort during the robotic blood draw.
  • Robotic phlebotomy aims to support rather than replace manual phlebotomy.
  • Potential for automation in workflow, including integration with pneumatic tube systems.
  • Younger patients showed more reservations compared to middle-aged and older patients.

Guideline-Based Recommendations

Diagnosis

  • Consideration of patient demographics in robotic phlebotomy suitability.

Management

  • Monitor patient feedback for continuous improvement.

Monitoring & Follow-up

    Risks

    • Occasional bruising similar to manual phlebotomy.

    Patient & Prescribing Data

    Adult patients in clinical settings.

    High patient enthusiasm and satisfaction with robotic blood draw.

    Clinical Best Practices

    • Communicate clearly that robotic systems support staff roles.
    • Focus on refining practical aspects such as bandage application and blood spillage.
    • Address patient concerns regarding automation and job security.

    Related Resources & Content

      This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

      Newsletters

      Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

      Newsletter Signup Image

      About the Author(s)

      Helen Bristow

      Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

      More Articles by Helen Bristow

      Explore More in Pathology

      Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

      False

      Advertisement

      Recommended

      False

      Related Content

      Breathing New Life into Diagnostics
      Technology and innovation
      Breathing New Life into Diagnostics

      January 22, 2024

      6 min read

      Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

      Opening a Window into Brain Trauma
      Technology and innovation
      Opening a Window into Brain Trauma

      January 18, 2024

      4 min read

      Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

      Molecular Spectacular
      Technology and innovation
      Molecular Spectacular

      January 8, 2024

      1 min read

      A look at last year’s most interesting molecular pathology stories

      Cracking Colon Cancer
      Technology and innovation
      Cracking Colon Cancer

      January 25, 2024

      1 min read

      How a new clinically approved AI-based tool enables rapid microsatellite instability detection

      Affiliations:

      Specialties:

      Areas of Expertise:

      Contributions:

      False

      The Pathologist
      Subscribe

      About

      • About Us
      • Work at Conexiant Europe
      • Terms and Conditions
      • Privacy Policy
      • Advertise With Us
      • Contact Us

      Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.